On Monday, the Open Neurology Journal published a review of several recent clinical trials assessing the safety of medical marijuana that found marijuana's current placement as a Schedule I controlled substance with no medical value in not scientifically justified. "Based on evidence currently available, the Schedule I classification is not tenable; it is not accurate that marijuana has no medical use, or that information on safety is lacking," the authors wrote. The lead author is Dr. Igor Grant, director of the Center for Medicinal Cannabis Research. The review and its conclusions directly contradict the stance of the DEA and FDA.
Don't Like The Laws?
Change The Law Makers!
The administrator has disabled public write access.